Extranodal Marginal Zone Lymphoma
3 clinical trials · Condition
◉ Watch Extranodal Marginal Zone Lymphoma
| Record | Firm | Date |
|---|---|---|
| Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma (NCT07583810) | City of Hope Medical Center | 2026-12-16 |
| Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (NCT06569680) | Izidore Lossos, MD | 2024-11-19 |
| Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma (NCT04465162) | M.D. Anderson Cancer Center | 2000-06-07 |
Track Extranodal Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.